IP Library Granted Patent US 11,932,667
Granted Patent B1
US 11,932,667 · App. 17/185,788 · Granted Mar 19, 2024

Expression and purification of Cas enzymes

Inventors: Sarah Franz Beaudoin (Iowa City, IA); Michael Allen Collingwood (North Liberty, IA); Christopher Anthony Vakulskas (North Liberty, IA); Mark Aaron Behlke (Coralville, IA)
Assignee: INTEGRATED DNNA TECHNOLOGIES INC.
C07K1/36C07K1/18C07K1/22C12N9/22C12Y301/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,932,667
App. No.
17/185,788
Granted
Mar 19, 2024
Kind
B1
Abstract

Described herein are methods for the expression and purification of Cas13a and methods for detecting target RNA using Cas13a.

Claims (33)

1. A method for expressing and purifying a Cas13a protein, the method comprising:

(a) inserting a nucleotide sequence encoding a polypeptide having the polypeptide sequences of SEQ ID NO: 10 into an expression plasmid;

(b) transforming one or more cells with the expression plasmid;

(c) inducing expression of the transformed plasmid;

(d) isolating the cells;

(e) extracting the Cas13a protein; and

(f) purifying the protein using affinity purification and ion exchange purification.

2. The method of claim 1 , wherein the cell comprises E. coli BL21(DE3).

3. The method of claim 1 , wherein the expression plasmid comprises pET28 or pET28-MBP-TEV plasmids.

4. The method of claim 1 , wherein the nucleotide sequence is inserted into the expression plasmid using isothermal assembly.

5. The method of claim 1 , wherein the affinity purification comprises a nickel or a maltose affinity media.

6. The method of claim 1 , wherein the affinity purification comprises affinity chromatography comprising:

(f(1) a equilibrating a nickel affinity column with a binding buffer and loading the extracted Cas13a protein;

f(2) washing the nickel affinity column with a wash buffer; and

f(3) eluting the affinity purified Cas13a protein from the nickel affinity column using elution buffer.

7. The method of claim 1 , wherein the affinity purification comprises affinity chromatography comprising:

f(1) equilibrating a maltose affinity column with a binding buffer and loading the extracted Cas13a protein;

f(2) washing the maltose affinity column with a wash buffer; and

f(3) eluting the affinity purified Cas13a protein from the maltose affinity column using elution buffer.

8. The method of claim 1 , wherein the ion exchange purification comprises a cation exchange media.

9. The method of claim 1 , wherein the ion exchange purification comprises cation exchange chromatography comprising:

(1) equilibrating a cation exchange column with a binding buffer and loading the extracted Cas13a protein;

(2) washing the cation exchange column with a wash buffer; and

(3) eluting the cation exchange purified Cas13a protein from the cation exchange column using an elution buffer.

10. The method of claim 1 , further comprising concentrating the purified Cas13a protein to approximately 10 mg/mL.

11. The method of claim 10 , further comprising dialyzing the concentrated purified Cas13a protein.

12. A method for purifying a recombinant Cas13a protein, the method comprising:

(a) providing an expressed recombinant Cas13a protein having the polypeptide sequence of SEQ ID NO: 10;

(b) performing an affinity purification comprising a nickel affinity media or a maltose affinity media;

(c) performing an ion exchange purification comprising a cation exchange media; and

(d) collecting the purified Cas13a protein.

13. The method of claim 12 , further comprising concentrating the purified Cas13a protein to approximately 10 mg/mL.

14. The method of claim 13 , further comprising dialyzing the concentrated purified Cas13a protein against three rounds of dialysis buffer.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2023
From: BEAUDOIN, SARAH FRANZ; COLLINGWOOD, MICHAEL ALLEN; VAKULSKAS, CHRISTOPHER ANTHONY; BEHLKE, MARK AARON
To: INTEGRATED DNA TECHNOLOGIES, INC.
Reel/Frame 065595/0774 →
Continuity (1)
Provisional Application 62982231 · Feb 27, 2020